Impact of intermittent fasting on health and disease processes - PubMed (original) (raw)
Review
Impact of intermittent fasting on health and disease processes
Mark P Mattson et al. Ageing Res Rev. 2017 Oct.
Abstract
Humans in modern societies typically consume food at least three times daily, while laboratory animals are fed ad libitum. Overconsumption of food with such eating patterns often leads to metabolic morbidities (insulin resistance, excessive accumulation of visceral fat, etc.), particularly when associated with a sedentary lifestyle. Because animals, including humans, evolved in environments where food was relatively scarce, they developed numerous adaptations that enabled them to function at a high level, both physically and cognitively, when in a food-deprived/fasted state. Intermittent fasting (IF) encompasses eating patterns in which individuals go extended time periods (e.g., 16-48h) with little or no energy intake, with intervening periods of normal food intake, on a recurring basis. We use the term periodic fasting (PF) to refer to IF with periods of fasting or fasting mimicking diets lasting from 2 to as many as 21 or more days. In laboratory rats and mice IF and PF have profound beneficial effects on many different indices of health and, importantly, can counteract disease processes and improve functional outcome in experimental models of a wide range of age-related disorders including diabetes, cardiovascular disease, cancers and neurological disorders such as Alzheimer's disease Parkinson's disease and stroke. Studies of IF (e.g., 60% energy restriction on 2days per week or every other day), PF (e.g., a 5day diet providing 750-1100kcal) and time-restricted feeding (TRF; limiting the daily period of food intake to 8h or less) in normal and overweight human subjects have demonstrated efficacy for weight loss and improvements in multiple health indicators including insulin resistance and reductions in risk factors for cardiovascular disease. The cellular and molecular mechanisms by which IF improves health and counteracts disease processes involve activation of adaptive cellular stress response signaling pathways that enhance mitochondrial health, DNA repair and autophagy. PF also promotes stem cell-based regeneration as well as long-lasting metabolic effects. Randomized controlled clinical trials of IF versus PF and isoenergetic continuous energy restriction in human subjects will be required to establish the efficacy of IF in improving general health, and preventing and managing major diseases of aging.
Keywords: Alzheimer’s disease; Blood pressure; Cardiovascular disease; Diabetes; Insulin resistance; Intermittent fasting; Ketone bodies; Obesity.
Published by Elsevier B.V.
Figures
Fig. 1
Examples of the influence of eating patterns on levels of glucose at ketones in the blood. The red arrows indicate the time of food consumption/meals during a 2 day period of time. A. This is an example of the typical eating pattern in most industrialized countries. Every day the person eats breakfast, lunch and dinner and a late evening snack. With each meal, glucose levels are elevated and then return towards baseline over a period of several hours. Ketone levels remain low, because liver glycogen stores are never depleted. B. This is an example of fasting one day, followed by a three-meal feeding day. During the fasting day, glucose levels remain in the low normal range, and ketone levels (β-hydroxybutyrate and acetoacetate) rise progressively, and then fall when the first meal is consumed on the 2nd day. C. This is an example of an eating pattern in which all food is consumed within a 6h time window each day. Glucose levels are elevated during and for several hours after the 6h period of food consumption and then remain low for the subsequent 16 h until food is consumed the next day. Ketones are elevated during the last 6–8 h of the 18 h fasting period.
Fig. 2
Patterns of energy intake in subject on either the ‘5:2′ intermittent energy restriction (IER) diet or continuous (daily) energy restriction (CER). Based on Harvie et al., 2011.
Fig. 3
Examples of effects of intermittent fasting on different organ systems. Abbreviations;: 30HB, 3-hydroxybutyrate; CRP, C-reactive protein; IGF-1, insulin-like growth factor 1; IL-6, interleukin 6; TNFα, tumor necrosis factor α
Similar articles
- Meal pattern alterations associated with intermittent fasting for weight loss are normalized after high-fat diet re-feeding.
Gotthardt JD, Bello NT. Gotthardt JD, et al. Physiol Behav. 2017 May 15;174:49-56. doi: 10.1016/j.physbeh.2017.02.046. Epub 2017 Mar 3. Physiol Behav. 2017. PMID: 28263771 - Intermittent fasting interventions for the treatment of overweight and obesity in adults aged 18 years and over: a systematic review protocol.
Jane L, Atkinson G, Jaime V, Hamilton S, Waller G, Harrison S. Jane L, et al. JBI Database System Rev Implement Rep. 2015 Oct;13(10):60-8. doi: 10.11124/jbisrir-2015-2363. JBI Database System Rev Implement Rep. 2015. PMID: 26571283 - Time-restricted feeding improves insulin resistance and hepatic steatosis in a mouse model of postmenopausal obesity.
Chung H, Chou W, Sears DD, Patterson RE, Webster NJ, Ellies LG. Chung H, et al. Metabolism. 2016 Dec;65(12):1743-1754. doi: 10.1016/j.metabol.2016.09.006. Epub 2016 Sep 22. Metabolism. 2016. PMID: 27832862 Free PMC article. - Fasting for weight loss: an effective strategy or latest dieting trend?
Johnstone A. Johnstone A. Int J Obes (Lond). 2015 May;39(5):727-33. doi: 10.1038/ijo.2014.214. Epub 2014 Dec 26. Int J Obes (Lond). 2015. PMID: 25540982 Review. - Rationale for novel intermittent dieting strategies to attenuate adaptive responses to energy restriction.
Sainsbury A, Wood RE, Seimon RV, Hills AP, King NA, Gibson AA, Byrne NM. Sainsbury A, et al. Obes Rev. 2018 Dec;19 Suppl 1:47-60. doi: 10.1111/obr.12787. Obes Rev. 2018. PMID: 30511512 Review.
Cited by
- The neurovascular unit and systemic biology in stroke - implications for translation and treatment.
Tiedt S, Buchan AM, Dichgans M, Lizasoain I, Moro MA, Lo EH. Tiedt S, et al. Nat Rev Neurol. 2022 Oct;18(10):597-612. doi: 10.1038/s41582-022-00703-z. Epub 2022 Sep 9. Nat Rev Neurol. 2022. PMID: 36085420 Review. - Intermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach.
Brogi S, Tabanelli R, Puca S, Calderone V. Brogi S, et al. Foods. 2024 Jun 21;13(13):1960. doi: 10.3390/foods13131960. Foods. 2024. PMID: 38998465 Free PMC article. Review. - Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity.
Barradas M, Plaza A, Colmenarejo G, Lázaro I, Costa-Machado LF, Martín-Hernández R, Micó V, López-Aceituno JL, Herranz J, Pantoja C, Tejero H, Diaz-Ruiz A, Al-Shahrour F, Daimiel L, Loria-Kohen V, Ramirez de Molina A, Efeyan A, Serrano M, Pozo OJ, Sala-Vila A, Fernandez-Marcos PJ. Barradas M, et al. Nat Commun. 2022 Sep 27;13(1):5677. doi: 10.1038/s41467-022-33352-3. Nat Commun. 2022. PMID: 36167809 Free PMC article. - The Christian Orthodox Church Fasting Diet Is Associated with Lower Levels of Depression and Anxiety and a Better Cognitive Performance in Middle Life.
Spanaki C, Rodopaios NE, Koulouri A, Pliakas T, Papadopoulou SK, Vasara E, Skepastianos P, Serafeim T, Boura I, Dermitzakis E, Kafatos A. Spanaki C, et al. Nutrients. 2021 Feb 15;13(2):627. doi: 10.3390/nu13020627. Nutrients. 2021. PMID: 33671993 Free PMC article. - Dietary Regulation of Memory T Cells.
Collins N. Collins N. Int J Mol Sci. 2020 Jun 19;21(12):4363. doi: 10.3390/ijms21124363. Int J Mol Sci. 2020. PMID: 32575427 Free PMC article. Review.
References
- Ahmet I, Wan R, Mattson MP, Lakatta EG, Talan M. Cardioprotection by intermittent fasting in rats. Circulation. 2005;112:3115–3121. - PubMed
- Anastasiou CA, Karfopoulou E, Yannakoulia M. Weight regaining: from statistics and behaviors to physiology and metabolism. Metabolism. 2015;64:1395–1407. - PubMed
- Anson RM, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A, Ingram DK, Lane MA, Mattson MP. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc. Natl. Acad. Sci. U. S. A. 2003;100:6216–6220. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- ZIA AG000315-15/Intramural NIH HHS/United States
- ZIA AG000315-16/Intramural NIH HHS/United States
- ZIA AG000317-16/Intramural NIH HHS/United States
- ZIA AG000331-08/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous